CLBX - Ticker AI Digest

CelLBxHealth plc 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (CLBX) 1
CLBX 06:01
CelLBxHealth plc
Aligning Regulatory Approach with Commercial Needs
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
CLBX 06:01
CelLBxHealth plc
Preliminary Fourth Quarter 2025 Financial Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
CelLBxHealth PLC, a leader in circulating tumour cell (CTC) intelligence, released its preliminary fourth-quarter 2025 financial results on January 16, 2026. The company reported lower-than-expected revenues of approximately £0.4 million for Q4 and £1.4 million for the full year 2025, primarily due to deferred sales contracts worth £0.2 million into Q1 2026. Despite this, the company maintains a strong cash position of £7.3 million.
To streamline operations and reduce costs, CelLBxHealth has
1. Delisted from the OTCQX Market, transitioning to the Pink Limited Market.
2. Consolidated its Guildford operations into a single facility.
3. Implemented headcount reductions and restructuring, expecting annual cost savings of £5.9 million.
Looking ahead to 2026, the company is focused on executing its revised business strategy, targeting commercial milestones from a qualified sales pipeline of £12.6 million (risk-weighted £4.5 million). The 2026 reporting calendar includes quarterly financial updates and a preliminary FY2025 results announcement in June. CEO Peter Collins emphasized the companys progress in organizational restructuring and cost-saving measures, while acknowledging the deferred sales impact on 2025 results.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 2
CLBX 06:01
CelLBxHealth plc
Aligning Regulatory Approach with Commercial Needs
CLBX 06:01
CelLBxHealth plc
Preliminary Fourth Quarter 2025 Financial Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
CelLBxHealth PLC, a leader in circulating tumour cell (CTC) intelligence, released its preliminary fourth-quarter 2025 financial results on January 16, 2026. The company reported lower-than-expected revenues of approximately £0.4 million for Q4 and £1.4 million for the full year 2025, primarily due to deferred sales contracts worth £0.2 million into Q1 2026. Despite this, the company maintains a strong cash position of £7.3 million.
To streamline operations and reduce costs, CelLBxHealth has
1. Delisted from the OTCQX Market, transitioning to the Pink Limited Market.
2. Consolidated its Guildford operations into a single facility.
3. Implemented headcount reductions and restructuring, expecting annual cost savings of £5.9 million.
Looking ahead to 2026, the company is focused on executing its revised business strategy, targeting commercial milestones from a qualified sales pipeline of £12.6 million (risk-weighted £4.5 million). The 2026 reporting calendar includes quarterly financial updates and a preliminary FY2025 results announcement in June. CEO Peter Collins emphasized the companys progress in organizational restructuring and cost-saving measures, while acknowledging the deferred sales impact on 2025 results.

AI Crunch

Single-Ticker AI Crunch
CLBX signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for CelLBxHealth plc. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full CLBX AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for CLBX on 2026-02-13.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
7740682
Enterprise Value
-
Public Float
73.85
Broker Target
10.5
Shares Out
322528409
Long Interest
-
Short Interest
-
Exchange
-
Currency Code
-
ISIN
None
Market
None
Sector
-
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
-
Net Debt
-
Cash
10425000.0
EPS
-0.05
Net Income
-14225000.0
Revenue
2862000.0
Enterprise Value
-
Trailing PE
-
Forward PE
-
Price Sales TTM
2.95
Price Book MRQ
0.7585
EV Revenue
2.7689
EV EBITDA
-1.6211

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
29.9
Institutions As Of
2025-12-23
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
0
Sale Director Dealing
0
Purchase TR1
1
Sale TR1
0
Broker Coverage Rows
0
Institution Holders Tracked
1
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit CLBX.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-02-13 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
CelLBxHealth plc has fresh news flow feeding the chart narrative.
06:01 Today's Catalyst Aligning Regulatory Approach with Commercial Needs
AI Charts Studio
CLBX Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-02-13 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
RSI Gauge
Price Change
AI Forecast